Terms: = Thyroid cancer AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A AND Prognosis
219 results:
1. Natural History and Prognostic Model of Untreated Papillary thyroid cancer: A SEER Database Analysis.
Wang D; Yang Y; He Y; Yang H; Yang L
Cancer Control; 2024; 31():10732748241253956. PubMed ID: 38756002
[TBL] [Abstract] [Full Text] [Related]
2. Risk assessment model based on nucleotide metabolism-related genes highlights SLC27A2 as a potential therapeutic target in breast cancer.
Zhang B; Zhang Y; Chang K; Hou N; Fan P; Ji C; Liu L; Wang Z; Li R; Wang Y; Zhang J; Ling R
J Cancer Res Clin Oncol; 2024 May; 150(5):258. PubMed ID: 38753091
[TBL] [Abstract] [Full Text] [Related]
3. Significance of
Lin H; Wang J; Shi Q; Wu M
PeerJ; 2024; 12():e17338. PubMed ID: 38708353
[TBL] [Abstract] [Full Text] [Related]
4. VDR is a potential prognostic biomarker and positively correlated with immune infiltration: a comprehensive pan-cancer analysis with experimental verification.
Xia X; Xu F; Dai D; Xiong A; Sun R; Ling Y; Qiu L; Wang R; Ding Y; Lin M; Li H; Xie Z
Biosci Rep; 2024 May; 44(5):. PubMed ID: 38639057
[TBL] [Abstract] [Full Text] [Related]
5. Comprehensive bioinformatics analysis unveils THEMIS2 as a carcinogenic indicator related to immune infiltration and prognosis of thyroid cancer.
Liu JF; Zou B; Xiang C; Yan HC
Sci Rep; 2024 Apr; 14(1):8156. PubMed ID: 38589421
[TBL] [Abstract] [Full Text] [Related]
6. Upregulation of ESPL1 is associated with poor prognostic outcomes in endometrial cancer.
Yang Y; Sheng Y; Zheng J; Ma A; Chen S; Lin J; Yang X; Liang Y; Zhang Y; Zheng X
Biomarkers; 2024 Jun; 29(4):185-193. PubMed ID: 38568742
[TBL] [Abstract] [Full Text] [Related]
7. Development and validation of a nomogram model for predicting distant metastasis of aged ≥50 patients with thyroid carcinoma: a SEER database analysis.
Yu JW; Pang R; Liu B; Zhang L; Kong LY
Eur Rev Med Pharmacol Sci; 2024 Mar; 28(6):2351-2362. PubMed ID: 38567598
[TBL] [Abstract] [Full Text] [Related]
8. Development and validation of a nomogram for predicting lymph node metastasis in ductal carcinoma in situ with microinvasion: A SEER population-based study.
Zhu K; Sui Y; Zhu M; Gao Y; Yuan Y; Sun P; Meng L; Dai J; Li Z
PLoS One; 2024; 19(4):e0301057. PubMed ID: 38557552
[TBL] [Abstract] [Full Text] [Related]
9. Novel prognostic biomarker TBC1D1 is associated with immunotherapy resistance in gliomas.
Song D; Yang Q; Li L; Wei Y; Zhang C; Du H; Ren G; Li H
Front Immunol; 2024; 15():1372113. PubMed ID: 38529286
[TBL] [Abstract] [Full Text] [Related]
10. Low expression of fatty acid oxidation related gene ACADM indicates poor prognosis of renal clear cell carcinoma and is related to tumor immune infiltration.
Qiu J; Yang T; Sun Y; Sun K; Xu Y; Xia Q
Oncol Res; 2024; 32(3):545-561. PubMed ID: 38361759
[TBL] [Abstract] [Full Text] [Related]
11. Identification and validation of a copper homeostasis-related gene signature for the predicting prognosis of breast cancer patients via integrated bioinformatics analysis.
Li Y; Wei X; Wang Y; Wang W; Zhang C; Kong D; Liu Y
Sci Rep; 2024 Feb; 14(1):3141. PubMed ID: 38326441
[TBL] [Abstract] [Full Text] [Related]
12. An analysis of the prognostic role of reactive oxygen species-associated genes in breast cancer.
Zhong Y; Cao H; Li W; Deng J; Li D; Deng J
Environ Toxicol; 2024 May; 39(5):3055-3148. PubMed ID: 38319140
[TBL] [Abstract] [Full Text] [Related]
13. [TRIP13 Enhances Radioresistance of Lung Adenocarcinoma Cells
through the Homologous Recombination Pathway].
Ge S; Gu R; Yang X; Xu C; Wang S; Zhu G
Zhongguo Fei Ai Za Zhi; 2024 Jan; 27(1):1-12. PubMed ID: 38296621
[TBL] [Abstract] [Full Text] [Related]
14. Bioinformatics analysis identifies coagulation factor II receptor as a potential biomarker in stomach adenocarcinoma.
Wu X; Wang S; Wang C; Wu C; Zhao Z
Sci Rep; 2024 Jan; 14(1):2468. PubMed ID: 38291086
[TBL] [Abstract] [Full Text] [Related]
15. prognosis and therapy in thyroid cancer by gene signatures related to natural killer cells.
Jin Z; Han Y; Zhang J; Liu Z; Li R; Liu Z
J Gene Med; 2024 Jan; 26(1):e3657. PubMed ID: 38282150
[TBL] [Abstract] [Full Text] [Related]
16. Novel quantitative immunohistochemistry method using histone H3, family 3B as the internal reference standard for measuring human epidermal growth factor receptor 2 expression in breast cancer.
Wang J; Xia YC; Tian BX; Li JT; Li HY; Dong H; Li XG; Yu H; Zhu YY; Ma J; Jiang YJ; Jin GZ
Cancer; 2024 Apr; 130(S8):1424-1434. PubMed ID: 38217532
[TBL] [Abstract] [Full Text] [Related]
17. HDAC inhibitors target IRS4 to enhance anti‑AR therapy in AR‑positive triple‑negative breast cancer.
He Y; Ma Y; Zhu Y; Zhang J; Zhao S; Zhang D; Xu D; Li Y; Tong Z; Zhao W
Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38214343
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic value and potential mechanism of cellular senescence and tumor microenvironment in hepatocellular carcinoma: Insights from bulk transcriptomics and single-cell sequencing analysis.
Qu C; Wu Q; Lu J; Li F
Environ Toxicol; 2024 May; 39(5):2512-2527. PubMed ID: 38189188
[TBL] [Abstract] [Full Text] [Related]
19. Development and Validation of Potential Molecular Subtypes and Signatures of thyroid Carcinoma Based on Aging-related Gene Analysis.
Li Z; Jia LI; Zhou HR; Zhang LU; Zhang M; Lv J; Deng ZY; Liu C
Cancer Genomics Proteomics; 2024; 21(1):102-117. PubMed ID: 38151291
[TBL] [Abstract] [Full Text] [Related]
20. Notch3 restricts metastasis of breast cancers through regulation of the JAK/STAT5A signaling pathway.
Chen MN; Fang ZX; Wu Z; Bai JW; Li RH; Wen XF; Zhang GJ; Liu J
BMC Cancer; 2023 Dec; 23(1):1257. PubMed ID: 38124049
[TBL] [Abstract] [Full Text] [Related]
[Next]